Pfizer, BioNTech announce early positive date from ongoing Phase 1/2 study of coronavirus vaccine…
With the eyes of the world turned on the global COVID-19 vaccine race, Pfizer and its partner BioNTech posted early positive data from one of their four candidates. With this first win — and other data yet to come— the partners are prepping…